Loading…

Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin

Second-generation antipsychotics (SGAs) have been associated with an increased liability for weight gain and metabolic side effects. Among SGAs, clozapine and olanzapine had great liability to induce weight gain and metabolic adverse reactions. Leptin, adiponectin, and total ghrelin play important r...

Full description

Saved in:
Bibliographic Details
Published in:Progress in neuro-psychopharmacology & biological psychiatry 2015-04, Vol.58, p.47-50
Main Authors: Lu, Mong-Liang, Wang, Tsu-Nai, Lin, Tsang-Yaw, Shao, Wen-Chuan, Chang, Sheng-Huang, Chou, Jen-Yu, Ho, Yi-Feng, Liao, Yin-To, Chen, Vincent Chin-Hung
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3
cites cdi_FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3
container_end_page 50
container_issue
container_start_page 47
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 58
creator Lu, Mong-Liang
Wang, Tsu-Nai
Lin, Tsang-Yaw
Shao, Wen-Chuan
Chang, Sheng-Huang
Chou, Jen-Yu
Ho, Yi-Feng
Liao, Yin-To
Chen, Vincent Chin-Hung
description Second-generation antipsychotics (SGAs) have been associated with an increased liability for weight gain and metabolic side effects. Among SGAs, clozapine and olanzapine had great liability to induce weight gain and metabolic adverse reactions. Leptin, adiponectin, and total ghrelin play important roles in energy homeostasis and are suggested to be biomarkers of metabolic disturbances. The purpose of the present study was to investigate the differential effects of antipsychotics (olanzapine and clozapine) on the levels of adipocytokines (leptin and adiponectin) and total ghrelin. Three hundred and thirty-three patients with schizophrenia under clozapine or olanzapine monotherapy were recruited. Control participants were recruited from a healthy community population based on a health investigation (N=119). Fasting blood samples for glucose, cholesterol, triglycerides, leptin, adiponectin, and total ghrelin were analyzed. There were significant differences in the levels of cholesterol, triglycerides, and glucose between these three groups. Post hoc comparisons showed that the olanzapine group had the highest levels of cholesterol and triglycerides. The levels of leptin, adiponectin, and total ghrelin were also significantly different between the three groups after controlling age and body mass index (BMI). Post hoc comparisons showed that the olanzapine group had the lowest levels of adiponectin and total ghrelin. The present study found that the uses of olanzapine and clozapine were associated with changes in adipocytokines and total ghrelin, even after adjusting potential confounding factors. Olanzapine had greater influences on adiponectin and total ghrelin than clozapine. The changes in adipocytokines and total ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis, rather than the result of weight gain. •Olanzapine and clozapine were associated with changes in levels of adipocytokines and total ghrelin.•Olanzapine had greater influences on adiponectin and ghrelin levels than clozapine.•The changes in adipocytokines and ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis.
doi_str_mv 10.1016/j.pnpbp.2014.12.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1658420235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584614002383</els_id><sourcerecordid>1658420235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhq0K1IS0vwCp2iOXbO2x1-scekBAS6VIXNqz5V2Pi1NnvbU3SPTX43zAkdO8Iz0zo3kIuWS0ZpTJr5t6HMZurIEyUTOoKWUfyJypVi0FMHlG5hRKbpSQM3KR84YWglP-kcygESupYDUneOudw4TD5E2osOR-ylV0VQxm-G9GP2BlBlv1IZ66OFRjMHlrqoBPGA6wsX6M_fMU_xYiHwamOJWFfx4TBj98IufOhIyfT3VBfn-_-3Vzv1w__Ph5c71e9gKaaWmZUKZpJaoWGmg7Bo4zR61B40BZw4VskDe2WyneUtMCRSY4COUMyJXs-IJcHfeOKf7bYZ701uceQ_kF4y5rJosNoMCbgvIj2qeYc0Knx-S3Jj1rRvXer97og1-996sZ6L29BflyOrDrtmjfZl6FFuDbEShm8Mlj0rn3OPRofSpqtY3-3QMvvfeNvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1658420235</pqid></control><display><type>article</type><title>Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Lu, Mong-Liang ; Wang, Tsu-Nai ; Lin, Tsang-Yaw ; Shao, Wen-Chuan ; Chang, Sheng-Huang ; Chou, Jen-Yu ; Ho, Yi-Feng ; Liao, Yin-To ; Chen, Vincent Chin-Hung</creator><creatorcontrib>Lu, Mong-Liang ; Wang, Tsu-Nai ; Lin, Tsang-Yaw ; Shao, Wen-Chuan ; Chang, Sheng-Huang ; Chou, Jen-Yu ; Ho, Yi-Feng ; Liao, Yin-To ; Chen, Vincent Chin-Hung</creatorcontrib><description>Second-generation antipsychotics (SGAs) have been associated with an increased liability for weight gain and metabolic side effects. Among SGAs, clozapine and olanzapine had great liability to induce weight gain and metabolic adverse reactions. Leptin, adiponectin, and total ghrelin play important roles in energy homeostasis and are suggested to be biomarkers of metabolic disturbances. The purpose of the present study was to investigate the differential effects of antipsychotics (olanzapine and clozapine) on the levels of adipocytokines (leptin and adiponectin) and total ghrelin. Three hundred and thirty-three patients with schizophrenia under clozapine or olanzapine monotherapy were recruited. Control participants were recruited from a healthy community population based on a health investigation (N=119). Fasting blood samples for glucose, cholesterol, triglycerides, leptin, adiponectin, and total ghrelin were analyzed. There were significant differences in the levels of cholesterol, triglycerides, and glucose between these three groups. Post hoc comparisons showed that the olanzapine group had the highest levels of cholesterol and triglycerides. The levels of leptin, adiponectin, and total ghrelin were also significantly different between the three groups after controlling age and body mass index (BMI). Post hoc comparisons showed that the olanzapine group had the lowest levels of adiponectin and total ghrelin. The present study found that the uses of olanzapine and clozapine were associated with changes in adipocytokines and total ghrelin, even after adjusting potential confounding factors. Olanzapine had greater influences on adiponectin and total ghrelin than clozapine. The changes in adipocytokines and total ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis, rather than the result of weight gain. •Olanzapine and clozapine were associated with changes in levels of adipocytokines and total ghrelin.•Olanzapine had greater influences on adiponectin and ghrelin levels than clozapine.•The changes in adipocytokines and ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2014.12.001</identifier><identifier>PMID: 25496829</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adipokines - blood ; Adiponectin ; Adult ; Aging - blood ; Aging - drug effects ; Antipsychotic Agents - therapeutic use ; Benzodiazepines - therapeutic use ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Body Mass Index ; Cholesterol - blood ; Clozapine ; Clozapine - therapeutic use ; Fasting - blood ; Female ; Ghrelin ; Ghrelin - blood ; Humans ; Leptin ; Male ; Middle Aged ; Olanzapine ; Schizophrenia ; Schizophrenia - blood ; Schizophrenia - drug therapy ; Triglycerides - blood</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2015-04, Vol.58, p.47-50</ispartof><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3</citedby><cites>FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25496829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Mong-Liang</creatorcontrib><creatorcontrib>Wang, Tsu-Nai</creatorcontrib><creatorcontrib>Lin, Tsang-Yaw</creatorcontrib><creatorcontrib>Shao, Wen-Chuan</creatorcontrib><creatorcontrib>Chang, Sheng-Huang</creatorcontrib><creatorcontrib>Chou, Jen-Yu</creatorcontrib><creatorcontrib>Ho, Yi-Feng</creatorcontrib><creatorcontrib>Liao, Yin-To</creatorcontrib><creatorcontrib>Chen, Vincent Chin-Hung</creatorcontrib><title>Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Second-generation antipsychotics (SGAs) have been associated with an increased liability for weight gain and metabolic side effects. Among SGAs, clozapine and olanzapine had great liability to induce weight gain and metabolic adverse reactions. Leptin, adiponectin, and total ghrelin play important roles in energy homeostasis and are suggested to be biomarkers of metabolic disturbances. The purpose of the present study was to investigate the differential effects of antipsychotics (olanzapine and clozapine) on the levels of adipocytokines (leptin and adiponectin) and total ghrelin. Three hundred and thirty-three patients with schizophrenia under clozapine or olanzapine monotherapy were recruited. Control participants were recruited from a healthy community population based on a health investigation (N=119). Fasting blood samples for glucose, cholesterol, triglycerides, leptin, adiponectin, and total ghrelin were analyzed. There were significant differences in the levels of cholesterol, triglycerides, and glucose between these three groups. Post hoc comparisons showed that the olanzapine group had the highest levels of cholesterol and triglycerides. The levels of leptin, adiponectin, and total ghrelin were also significantly different between the three groups after controlling age and body mass index (BMI). Post hoc comparisons showed that the olanzapine group had the lowest levels of adiponectin and total ghrelin. The present study found that the uses of olanzapine and clozapine were associated with changes in adipocytokines and total ghrelin, even after adjusting potential confounding factors. Olanzapine had greater influences on adiponectin and total ghrelin than clozapine. The changes in adipocytokines and total ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis, rather than the result of weight gain. •Olanzapine and clozapine were associated with changes in levels of adipocytokines and total ghrelin.•Olanzapine had greater influences on adiponectin and ghrelin levels than clozapine.•The changes in adipocytokines and ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis.</description><subject>Adipokines - blood</subject><subject>Adiponectin</subject><subject>Adult</subject><subject>Aging - blood</subject><subject>Aging - drug effects</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Benzodiazepines - therapeutic use</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Body Mass Index</subject><subject>Cholesterol - blood</subject><subject>Clozapine</subject><subject>Clozapine - therapeutic use</subject><subject>Fasting - blood</subject><subject>Female</subject><subject>Ghrelin</subject><subject>Ghrelin - blood</subject><subject>Humans</subject><subject>Leptin</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Olanzapine</subject><subject>Schizophrenia</subject><subject>Schizophrenia - blood</subject><subject>Schizophrenia - drug therapy</subject><subject>Triglycerides - blood</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PGzEQhq0K1IS0vwCp2iOXbO2x1-scekBAS6VIXNqz5V2Pi1NnvbU3SPTX43zAkdO8Iz0zo3kIuWS0ZpTJr5t6HMZurIEyUTOoKWUfyJypVi0FMHlG5hRKbpSQM3KR84YWglP-kcygESupYDUneOudw4TD5E2osOR-ylV0VQxm-G9GP2BlBlv1IZ66OFRjMHlrqoBPGA6wsX6M_fMU_xYiHwamOJWFfx4TBj98IufOhIyfT3VBfn-_-3Vzv1w__Ph5c71e9gKaaWmZUKZpJaoWGmg7Bo4zR61B40BZw4VskDe2WyneUtMCRSY4COUMyJXs-IJcHfeOKf7bYZ701uceQ_kF4y5rJosNoMCbgvIj2qeYc0Knx-S3Jj1rRvXer97og1-996sZ6L29BflyOrDrtmjfZl6FFuDbEShm8Mlj0rn3OPRofSpqtY3-3QMvvfeNvg</recordid><startdate>20150403</startdate><enddate>20150403</enddate><creator>Lu, Mong-Liang</creator><creator>Wang, Tsu-Nai</creator><creator>Lin, Tsang-Yaw</creator><creator>Shao, Wen-Chuan</creator><creator>Chang, Sheng-Huang</creator><creator>Chou, Jen-Yu</creator><creator>Ho, Yi-Feng</creator><creator>Liao, Yin-To</creator><creator>Chen, Vincent Chin-Hung</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150403</creationdate><title>Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin</title><author>Lu, Mong-Liang ; Wang, Tsu-Nai ; Lin, Tsang-Yaw ; Shao, Wen-Chuan ; Chang, Sheng-Huang ; Chou, Jen-Yu ; Ho, Yi-Feng ; Liao, Yin-To ; Chen, Vincent Chin-Hung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adipokines - blood</topic><topic>Adiponectin</topic><topic>Adult</topic><topic>Aging - blood</topic><topic>Aging - drug effects</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Benzodiazepines - therapeutic use</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Body Mass Index</topic><topic>Cholesterol - blood</topic><topic>Clozapine</topic><topic>Clozapine - therapeutic use</topic><topic>Fasting - blood</topic><topic>Female</topic><topic>Ghrelin</topic><topic>Ghrelin - blood</topic><topic>Humans</topic><topic>Leptin</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Olanzapine</topic><topic>Schizophrenia</topic><topic>Schizophrenia - blood</topic><topic>Schizophrenia - drug therapy</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Mong-Liang</creatorcontrib><creatorcontrib>Wang, Tsu-Nai</creatorcontrib><creatorcontrib>Lin, Tsang-Yaw</creatorcontrib><creatorcontrib>Shao, Wen-Chuan</creatorcontrib><creatorcontrib>Chang, Sheng-Huang</creatorcontrib><creatorcontrib>Chou, Jen-Yu</creatorcontrib><creatorcontrib>Ho, Yi-Feng</creatorcontrib><creatorcontrib>Liao, Yin-To</creatorcontrib><creatorcontrib>Chen, Vincent Chin-Hung</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Mong-Liang</au><au>Wang, Tsu-Nai</au><au>Lin, Tsang-Yaw</au><au>Shao, Wen-Chuan</au><au>Chang, Sheng-Huang</au><au>Chou, Jen-Yu</au><au>Ho, Yi-Feng</au><au>Liao, Yin-To</au><au>Chen, Vincent Chin-Hung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2015-04-03</date><risdate>2015</risdate><volume>58</volume><spage>47</spage><epage>50</epage><pages>47-50</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Second-generation antipsychotics (SGAs) have been associated with an increased liability for weight gain and metabolic side effects. Among SGAs, clozapine and olanzapine had great liability to induce weight gain and metabolic adverse reactions. Leptin, adiponectin, and total ghrelin play important roles in energy homeostasis and are suggested to be biomarkers of metabolic disturbances. The purpose of the present study was to investigate the differential effects of antipsychotics (olanzapine and clozapine) on the levels of adipocytokines (leptin and adiponectin) and total ghrelin. Three hundred and thirty-three patients with schizophrenia under clozapine or olanzapine monotherapy were recruited. Control participants were recruited from a healthy community population based on a health investigation (N=119). Fasting blood samples for glucose, cholesterol, triglycerides, leptin, adiponectin, and total ghrelin were analyzed. There were significant differences in the levels of cholesterol, triglycerides, and glucose between these three groups. Post hoc comparisons showed that the olanzapine group had the highest levels of cholesterol and triglycerides. The levels of leptin, adiponectin, and total ghrelin were also significantly different between the three groups after controlling age and body mass index (BMI). Post hoc comparisons showed that the olanzapine group had the lowest levels of adiponectin and total ghrelin. The present study found that the uses of olanzapine and clozapine were associated with changes in adipocytokines and total ghrelin, even after adjusting potential confounding factors. Olanzapine had greater influences on adiponectin and total ghrelin than clozapine. The changes in adipocytokines and total ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis, rather than the result of weight gain. •Olanzapine and clozapine were associated with changes in levels of adipocytokines and total ghrelin.•Olanzapine had greater influences on adiponectin and ghrelin levels than clozapine.•The changes in adipocytokines and ghrelin were a direct effect of antipsychotics on hormonal pathways of energy homeostasis.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>25496829</pmid><doi>10.1016/j.pnpbp.2014.12.001</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2015-04, Vol.58, p.47-50
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_1658420235
source ScienceDirect Freedom Collection 2022-2024
subjects Adipokines - blood
Adiponectin
Adult
Aging - blood
Aging - drug effects
Antipsychotic Agents - therapeutic use
Benzodiazepines - therapeutic use
Blood Glucose - drug effects
Blood Glucose - metabolism
Body Mass Index
Cholesterol - blood
Clozapine
Clozapine - therapeutic use
Fasting - blood
Female
Ghrelin
Ghrelin - blood
Humans
Leptin
Male
Middle Aged
Olanzapine
Schizophrenia
Schizophrenia - blood
Schizophrenia - drug therapy
Triglycerides - blood
title Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T07%3A36%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20effects%20of%20olanzapine%20and%20clozapine%20on%20plasma%20levels%20of%20adipocytokines%20and%20total%20ghrelin&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Lu,%20Mong-Liang&rft.date=2015-04-03&rft.volume=58&rft.spage=47&rft.epage=50&rft.pages=47-50&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2014.12.001&rft_dat=%3Cproquest_cross%3E1658420235%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c425t-d148a576e872527b12f31f0daeaf28da3465e35db98370a720e143248fa2696b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1658420235&rft_id=info:pmid/25496829&rfr_iscdi=true